Showing results (1-10 of 267) with videos related to
Sort By:
Pageof 27
Cancer Treatment Reports|October 1, 1984
Anaphylactic reactions to diaziquoneJ G Posada, P J O'Dwyer, D F HothCancer Research|August 1, 1987
Role of thymidine in biochemical modulation: a reviewP J O'Dwyer, S A King, D F Hoth, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Methodology for the rational development of methotrexate analogs in the clinicB Leyland-Jones, P J O'Dwyer, D F Hoth, et al.Investigational New Drugs|January 1, 1987
5-MethyltetrahydrohomofolateP J O'Dwyer, B H Wagner, D F Hoth, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Hypersensitivity reactions to deoxycoformycinP J O'Dwyer, S A King, E Eisenhauer, et al.Oncology (Williston Park, N.Y.)|June 1, 1988
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemiaP J O'Dwyer, B D Cheson, B Leyland-Jones, et al.Investigational New Drugs|December 1, 1988
Pyrazole: preclinical reassessmentP J O'Dwyer, S A King, J Plowman, et al.Annals of Internal Medicine|May 1, 1988
2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drugP J O'Dwyer, B Wagner, B Leyland-Jones, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Trimetrexate: clinical development of a nonclassical antifolateP J O'Dwyer, R J DeLap, S A King, et al.Hospital Practice (Office Ed.)|September 25, 1992
Current status of HIV therapy: II. Opportunistic diseasesJ Feinberg, D F HothPageof 27